The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $808,094 in first-year total cost, median $249,734.
Most frequent study sections
- Special Emphasis Panel[ZRG1 CVRS-C (10)]1
- Special Emphasis Panel[ZRG1 IMST-B (12)]1
- Special Emphasis Panel[ZRG1 IMST-J (10)]1
Most frequent institutions
- ELECTRONIC BIOSCIENCES, INC.1
- LARIX BIOSCIENCE, LLC1
- TALUS BIOSCIENCE, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | Illuminating the "dark" kinases - effects on proteome translocation and chromatin binding1R43TR004221-01 | FEDERATION, ALEXANDER | TALUS BIOSCIENCE, INC., WA | $333,867 | ZRG1 |
| 2021 | Inhibiting GPR146 in hypercholesterolemia1R43HL156695-01A1 | LARRICK, JAMES WYU, BO | LARIX BIOSCIENCE, LLC, CA | $249,734 | ZRG1 |
| 2020 | High-throughput, Multiplexed, Commercialized Ion Channel Drug Screening1R43HL154846-01 | SCHIBEL, ANNA | ELECTRONIC BIOSCIENCES, INC., CA | $224,493 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.